Competing risk analyses: how are they different and why should you care?
R. Chappell. Clinical cancer research : an official journal of the American Association for Cancer Research, 18 (8):
2127-9(April 2012)6822<m:linebreak></m:linebreak>CI: (c)2012; JID: 9502500; CON: Clin Cancer Res. 2012 Apr 15;18(8):2301-8. PMID: 22282466; 2012/03/16 aheadofprint; ppublish;<m:linebreak></m:linebreak>Anàlisi de supervivència; Competing risks.
DOI: 10.1158/1078-0432.CCR-12-0455
Abstract
Competing risks are events in which at least one precludes the observation of the other, such as toxicity and death. This commentary discusses and distinguishes between the two common types of competing risk analyses, the Kaplan-Meier and cumulative incidence curves.
Clinical cancer research : an official journal of the American Association for Cancer Research
number
8
pages
2127-9
volume
18
city
Department of Biostatistics and Medical Informatics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53792, USA. chappell@stat.wisc.edu
%0 Journal Article
%1 Chappell2012
%A Chappell, Rick
%D 2012
%J Clinical cancer research : an official journal of the American Association for Cancer Research
%K DataInterpretation Humans Male Neoplasms Neoplasms:therapy ProportionalHazardsModels ProstaticNeoplasms ProstaticNeoplasms:therapy Statistical
%N 8
%P 2127-9
%R 10.1158/1078-0432.CCR-12-0455
%T Competing risk analyses: how are they different and why should you care?
%U http://www.ncbi.nlm.nih.gov/pubmed/22427347
%V 18
%X Competing risks are events in which at least one precludes the observation of the other, such as toxicity and death. This commentary discusses and distinguishes between the two common types of competing risk analyses, the Kaplan-Meier and cumulative incidence curves.
%@ 1078-0432; 1078-0432
@article{Chappell2012,
abstract = {Competing risks are events in which at least one precludes the observation of the other, such as toxicity and death. This commentary discusses and distinguishes between the two common types of competing risk analyses, the Kaplan-Meier and cumulative incidence curves.},
added-at = {2023-02-03T11:44:35.000+0100},
author = {Chappell, Rick},
biburl = {https://www.bibsonomy.org/bibtex/2ff4cfd09e3d82848c65c3d5aad3bab95/jepcastel},
city = {Department of Biostatistics and Medical Informatics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53792, USA. chappell@stat.wisc.edu},
doi = {10.1158/1078-0432.CCR-12-0455},
interhash = {84674695c3ec3011c06e6f9108d5d702},
intrahash = {ff4cfd09e3d82848c65c3d5aad3bab95},
isbn = {1078-0432; 1078-0432},
issn = {1078-0432},
journal = {Clinical cancer research : an official journal of the American Association for Cancer Research},
keywords = {DataInterpretation Humans Male Neoplasms Neoplasms:therapy ProportionalHazardsModels ProstaticNeoplasms ProstaticNeoplasms:therapy Statistical},
month = {4},
note = {6822<m:linebreak></m:linebreak>CI: (c)2012; JID: 9502500; CON: Clin Cancer Res. 2012 Apr 15;18(8):2301-8. PMID: 22282466; 2012/03/16 [aheadofprint]; ppublish;<m:linebreak></m:linebreak>Anàlisi de supervivència; Competing risks},
number = 8,
pages = {2127-9},
pmid = {22427347},
timestamp = {2023-02-03T11:44:35.000+0100},
title = {Competing risk analyses: how are they different and why should you care?},
url = {http://www.ncbi.nlm.nih.gov/pubmed/22427347},
volume = 18,
year = 2012
}